Alpha DNA Investment Management’s Workiva WK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,944
Closed -$1.43M 160
2021
Q4
$1.43M Buy
+10,944
New +$1.54M 0.9% 88
2021
Q2
Sell
-34
Closed -$3K 661
2021
Q1
$3K Buy
+34
New +$3.37K ﹤0.01% 527

Other funds holding WK

Alpha DNA Investment Management's WK Position: Q1 2022 in Review

Alpha DNA Investment Management sold out of Workiva (WK) in Q1 2022, closing a stake of 10,944 shares — an estimated $1.43M sold.

Alpha DNA Investment Management first reported a position in WK in Q1 2021 and held it in 2 quarters. The position peaked at $1.43M in Q4 2021. 288 funds tracked by Wall St. Rank hold WK as of Q1 2022.

  • Alpha DNA Investment Management reported no remaining Workiva position as of Q1 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 10,944 Workiva shares in Q1 2022, an estimated $1.43M.
  • Alpha DNA Investment Management first reported a position in Workiva in Q1 2021 and held it in 2 quarters.
  • Alpha DNA Investment Management's Workiva position peaked at $1.43M in Q4 2021.
  • 288 funds tracked by Wall St. Rank held Workiva as of Q1 2022.

Based on Alpha DNA Investment Management's 13F filing for Q1 2022, filed 13 May 2022.